1338 GMT - AstraZeneca shares hit their highest level on record after third-quarter earnings last week beat market expectations. A U.S. drug-pricing deal reached last month that eased policy uncertainty also supports gains for the British pharma group, which makes more than 40% of its sales in the U.S. Shares rose 2.5% in early trading after climbing to an all-time intraday high of 134.6 pounds. Shares are now trading at 133.48 pounds, valuing the company at 203.3 billion pounds. AstraZeneca remains the largest U.K.-listed stock by market capitalization. (william.gray@wsj.com)
(END) Dow Jones Newswires
November 11, 2025 08:38 ET (13:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.